查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1612108

酒精使用障礙市場：按治療類型、障礙類型、分銷管道分類 - 全球預測 2025-2030

Alcohol Use Disorder Market by Treatment Type (Behavioral Therapy, Detoxification, Inpatient Rehabilitation), Disorder Type (Alcohol Abuse, Alcohol Dependence, High-Functioning Alcoholism), Distribution Channel - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年酒精使用障礙市場價值為12.1億美元，預計到2024年將達到12.8億美元，複合年成長率為6.50%，到2030年將達到18.8億美元。

酒精使用障礙 (AUD) 包括各種導致痛苦和傷害的問題飲酒行為，其一般特徵是儘管會產生負面後果，但仍無法控制酒精攝取量。解決澳元問題的必要性源於其對公共衛生的重大影響，包括社會、經濟和健康相關的負擔。其範圍涵蓋旨在預防和治療、康復計劃、公共衛生舉措和政策制定的醫療干預措施。最終用途範圍主要包括醫療保健提供者、復健中心、製藥公司和政府機構。市場成長要素包括心理健康意識的提高、治療方法技術的進步以及政府促進公共衛生的措施。新藥和數位健康平台的快速發展為市場拓展提供了機會。在建議方面，公司可以利用個人化醫療和數位治療工具的不斷成長趨勢來提高用戶參與度和治療效果。

主要市場統計
基準年[2023] 12.1億美元
預計年份 [2024] 12.8億美元
預測年份 [2030] 18.8億美元
複合年成長率（%） 6.50%

然而，該市場面臨局限性，例如與澳元相關的恥辱、高昂的治療成本以及阻礙市場滲透的嚴格法律規範。此外，發展中地區的文化差異和意識缺乏也是成長的挑戰。技術創新的重點發展領域包括開發更有效、更少成癮的藥物、人工智慧主導的早期檢測和個人化治療計劃解決方案以及整合遠端醫療和常規治療的綜合支援系統等。這一市場趨勢揭示了結合藥理和行為干預的整體方法的趨勢。市場的本質是動態的，受到社會對心理健康態度不斷變化和快速發展的技術格局的推動。透過專注於綜合護理模式和利用資料分析，公司不僅可以改善治療結果，還可以透過有效解決酒精使用障礙來擴大其市場佔有率並確保強勁成長。

市場動態：針對快速發展的酒精使用障礙市場揭示的關鍵市場洞察

供需的動態交互作用正在改變酒精使用障礙市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 全球藥物濫用案例不斷增加
    • 政府預防、診斷和治療酒精成癮的措施和計劃
    • 傳播預防和管理飲酒的數位和遠端醫療策略
  • 市場限制因素
    • 性能限制和效率評估的複雜性
  • 市場機會
    • 提高酒精使用障礙治療和診斷有效性和效率的研究措施和進展
    • 繼續核准有助於管理酒精使用的設備、藥物和配方
  • 市場挑戰
    • 制定酒精使用疾患治療和診斷策略的複雜性

波特的五力：駕馭酒精使用障礙市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解酒精使用疾患市場的外在影響

外在宏觀環境因素在塑造酒精使用疾患市場的表現動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解酒精使用障礙市場的競爭格局

對酒精使用障礙市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 酒精使用疾患市場定位矩陣供應商績效評估

FPNV 定位矩陣是評估酒精使用障礙市場供應商的關鍵工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了酒精使用障礙市場的成功之路

對於旨在加強在全球市場的影響力的公司來說，酒精使用障礙市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 世界各地吸毒案件呈現上升趨勢
      • 政府預防、診斷和治療酒精濫用障礙的措施和計劃
      • 傳播預防和管理酒精消費的數位和遠端醫療策略
    • 抑制因素
      • 性能限制和評估效率的複雜性
    • 機會
      • 提高治療和診斷有效性和效率的研究舉措和進展
      • 幫助管理酒精攝取的設備、藥物和配方正在核准中
    • 任務
      • 制定治療和診斷策略的複雜性
  • 市場區隔分析
    • 治療類型：增加對行為療法的興趣，以有效控制酒精使用障礙
    • 分銷管道：增加零售藥局非處方藥的使用以支持康復
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章酒精使用疾患市場治療類型

  • 行為療法
  • 排毒
  • 住院復健
  • 藥物治療

第 7 章 按市場混亂類型分類的酒精使用障礙

  • 酗酒
  • 酒精成癮
  • 高功能酒精成癮

第8章酒精使用疾患市場：依通路

  • 醫院藥房
  • 零售藥局/藥局

第9章美洲酒精使用疾患市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太酒精使用疾患市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲的酒精使用疾患市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • 研究人員獲得 340 萬美元津貼，用於研究殘障人士的酒精使用障礙
    • Affect 籌集了 1600 萬美元的與成癮相關的資金籌措
    • Indivior 完成對 Opiant Pharmaceuticals, Inc. 的收購
  • 戰略分析和建議

公司名單

  • Addex Therapeutics
  • Adial Pharmaceuticals
  • Alkermes
  • Astellas Pharma
  • Beckley Psytech Limited
  • BioCorRx, Inc.
  • Bioprojet
  • Clairvoyant Therapeutics
  • Corcept Therapeutics Inc.
  • GlaxoSmithKline PLC
  • Indivior Inc.
  • Kinnov Therapeutics
  • Kinoxis Therapeutics
  • Lundbeck
  • MediciNova
  • Merck & Co. Inc.
  • Omeros Corporation
  • Otsuka Pharmaceuticals
  • Sun Pharmaceutical Industries Limited
  • Teva Pharmaceutical Industries Ltd.
Product Code: MRR-351BAD503A27

The Alcohol Use Disorder Market was valued at USD 1.21 billion in 2023, expected to reach USD 1.28 billion in 2024, and is projected to grow at a CAGR of 6.50%, to USD 1.88 billion by 2030.

Alcohol Use Disorder (AUD) encompasses a range of problematic drinking behaviors leading to distress or harm, and it is commonly characterized by an inability to control alcohol intake despite adverse consequences. The necessity for addressing AUD arises from its significant public health impact, which includes social, economic, and health-related burdens. Its application spans medical interventions, rehabilitation programs, public health initiatives, and policy-making aimed at prevention and treatment. The end-use scope primarily involves healthcare providers, rehabilitation centers, pharmaceutical companies, and government agencies. Market growth factors include increasing awareness of mental health, technological advancements in treatment methods, and government initiatives promoting public health. The surge in the development of novel pharmaceuticals and digital health platforms presents opportunities for market expansion. In terms of recommendations, businesses can leverage the growing trend towards personalized medicine and digital therapy tools to enhance user engagement and treatment efficacy.

KEY MARKET STATISTICS
Base Year [2023] USD 1.21 billion
Estimated Year [2024] USD 1.28 billion
Forecast Year [2030] USD 1.88 billion
CAGR (%) 6.50%

However, the market faces limitations such as stigmatization associated with AUD, high treatment costs, and stringent regulatory frameworks, which can hinder market penetration. Additionally, cultural variations and lack of awareness in developing regions pose challenges to growth. Key areas for innovation include the development of more effective and less addictive medications, AI-driven solutions for early detection and personalized treatment plans, and comprehensive support systems integrating telehealth with traditional therapy. Insights into this market reveal a trend towards holistic approaches that combine pharmacological and behavioral interventions. The nature of the market is dynamic, driven by shifting societal attitudes towards mental health and rapidly evolving technological landscapes. By focusing on integrated care models and leveraging data analytics, businesses can not only enhance treatment outcomes but also expand their market presence, ensuring robust growth in addressing Alcohol Use Disorder effectively.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Alcohol Use Disorder Market

The Alcohol Use Disorder Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing incidences of substance abuse cases across the world
    • Government initiatives and schemes to prevent, diagnose, and treat alcohol abuse disorder
    • Proliferation of digital and telehealth strategies for preventing and managing alcohol use
  • Market Restraints
    • Performance limitations and complexities in evaluating efficiency
  • Market Opportunities
    • Research initiatives and advancements to improve the efficacy and efficiency of alcohol use disorder therapeutics and diagnostics
    • Ongoing approvals for devices, drugs, and formulations that help manage alcohol use
  • Market Challenges
    • Complexities in developing alcohol use disorder therapeutics and diagnostics strategies

Porter's Five Forces: A Strategic Tool for Navigating the Alcohol Use Disorder Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Alcohol Use Disorder Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Alcohol Use Disorder Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Alcohol Use Disorder Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Alcohol Use Disorder Market

A detailed market share analysis in the Alcohol Use Disorder Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Alcohol Use Disorder Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Alcohol Use Disorder Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Alcohol Use Disorder Market

A strategic analysis of the Alcohol Use Disorder Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Alcohol Use Disorder Market, highlighting leading vendors and their innovative profiles. These include Addex Therapeutics, Adial Pharmaceuticals, Alkermes, Astellas Pharma, Beckley Psytech Limited, BioCorRx, Inc., Bioprojet, Clairvoyant Therapeutics, Corcept Therapeutics Inc., GlaxoSmithKline PLC, Indivior Inc., Kinnov Therapeutics, Kinoxis Therapeutics, Lundbeck, MediciNova, Merck & Co. Inc., Omeros Corporation, Otsuka Pharmaceuticals, Sun Pharmaceutical Industries Limited, and Teva Pharmaceutical Industries Ltd..

Market Segmentation & Coverage

This research report categorizes the Alcohol Use Disorder Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Treatment Type, market is studied across Behavioral Therapy, Detoxification, Inpatient Rehabilitation, and Medication.
  • Based on Disorder Type, market is studied across Alcohol Abuse, Alcohol Dependence, and High-Functioning Alcoholism.
  • Based on Distribution Channel, market is studied across Hospital Pharmacies and Retail Pharmacies & Drug Stores.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing incidences of substance abuse cases across the world
      • 5.1.1.2. Government initiatives and schemes to prevent, diagnose, and treat alcohol abuse disorder
      • 5.1.1.3. Proliferation of digital and telehealth strategies for preventing and managing alcohol use
    • 5.1.2. Restraints
      • 5.1.2.1. Performance limitations and complexities in evaluating efficiency
    • 5.1.3. Opportunities
      • 5.1.3.1. Research initiatives and advancements to improve the efficacy and efficiency of alcohol use disorder therapeutics and diagnostics
      • 5.1.3.2. Ongoing approvals for devices, drugs, and formulations that help manage alcohol use
    • 5.1.4. Challenges
      • 5.1.4.1. Complexities in developing alcohol use disorder therapeutics and diagnostics strategies
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Treatment Type: Rising preference for behavioral therapies to effectively control alcohol use disorder
    • 5.2.2. Distribution Channel: Increasing utilization of over-the-counter medications by retail pharmacies to support recovery
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Alcohol Use Disorder Market, by Treatment Type

  • 6.1. Introduction
  • 6.2. Behavioral Therapy
  • 6.3. Detoxification
  • 6.4. Inpatient Rehabilitation
  • 6.5. Medication

7. Alcohol Use Disorder Market, by Disorder Type

  • 7.1. Introduction
  • 7.2. Alcohol Abuse
  • 7.3. Alcohol Dependence
  • 7.4. High-Functioning Alcoholism

8. Alcohol Use Disorder Market, by Distribution Channel

  • 8.1. Introduction
  • 8.2. Hospital Pharmacies
  • 8.3. Retail Pharmacies & Drug Stores

9. Americas Alcohol Use Disorder Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Alcohol Use Disorder Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Alcohol Use Disorder Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Researchers Receive USD 3.4 Million Grant to Study Alcohol Use Disorder Among People with Disabilities
    • 12.3.2. Affect Raises USD 16 Million As Addiction-Related Financings Hold Strong
    • 12.3.3. Indivior Completes Acquisition of Opiant Pharmaceuticals, Inc.
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Addex Therapeutics
  • 2. Adial Pharmaceuticals
  • 3. Alkermes
  • 4. Astellas Pharma
  • 5. Beckley Psytech Limited
  • 6. BioCorRx, Inc.
  • 7. Bioprojet
  • 8. Clairvoyant Therapeutics
  • 9. Corcept Therapeutics Inc.
  • 10. GlaxoSmithKline PLC
  • 11. Indivior Inc.
  • 12. Kinnov Therapeutics
  • 13. Kinoxis Therapeutics
  • 14. Lundbeck
  • 15. MediciNova
  • 16. Merck & Co. Inc.
  • 17. Omeros Corporation
  • 18. Otsuka Pharmaceuticals
  • 19. Sun Pharmaceutical Industries Limited
  • 20. Teva Pharmaceutical Industries Ltd.

LIST OF FIGURES

  • FIGURE 1. ALCOHOL USE DISORDER MARKET RESEARCH PROCESS
  • FIGURE 2. ALCOHOL USE DISORDER MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES ALCOHOL USE DISORDER MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES ALCOHOL USE DISORDER MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC ALCOHOL USE DISORDER MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC ALCOHOL USE DISORDER MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ALCOHOL USE DISORDER MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ALCOHOL USE DISORDER MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ALCOHOL USE DISORDER MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. ALCOHOL USE DISORDER MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ALCOHOL USE DISORDER MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ALCOHOL USE DISORDER MARKET DYNAMICS
  • TABLE 7. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY BEHAVIORAL THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY DETOXIFICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY INPATIENT REHABILITATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY MEDICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY ALCOHOL ABUSE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY ALCOHOL DEPENDENCE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY HIGH-FUNCTIONING ALCOHOLISM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY RETAIL PHARMACIES & DRUG STORES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES ALCOHOL USE DISORDER MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC ALCOHOL USE DISORDER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA ALCOHOL USE DISORDER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 146. ALCOHOL USE DISORDER MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 147. ALCOHOL USE DISORDER MARKET, FPNV POSITIONING MATRIX, 2023